-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Vitro Biopharma, Inc. quarterly/annual Depreciation history and growth rate from Q4 2021 to Q2 2024.
- Vitro Biopharma, Inc. Depreciation for the quarter ending July 31, 2024 was $48.3K, a 21.7% increase year-over-year.
- Vitro Biopharma, Inc. Depreciation for the twelve months ending July 31, 2024 was $175K, a 11.1% increase year-over-year.
- Vitro Biopharma, Inc. annual Depreciation for 2023 was $153K, a 6.58% decline from 2022.
- Vitro Biopharma, Inc. annual Depreciation for 2022 was $164K.
- Vitro Biopharma, Inc. annual Depreciation for 2015 was $12.6K, a 12.9% decline from 2014.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)